Grey Street Capital’s Sanofi SNY Stock Holding History

Grey Street Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$487K	Buy	+10,014	New	+$489K	0.07%	298

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Grey Street Capital's SNY Position: Q1 2024 in Review

Grey Street Capital opened a new position in Sanofi (SNY) in Q1 2024: 10,014 shares worth $487K. The stake represents 0.07% of the portfolio and ranks #298 among its holdings.

713 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

Grey Street Capital held 10,014 shares of Sanofi worth $487K as of Q1 2024.
Sanofi was a new Grey Street Capital position in Q1 2024.
Sanofi made up 0.07% of Grey Street Capital's portfolio in Q1 2024, its #298 holding.
713 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.